» Articles » PMID: 35308306

Image Processing Improvements Afford Second-generation Handheld Optoacoustic Imaging of Breast Cancer Patients

Overview
Journal Photoacoustics
Date 2022 Mar 21
PMID 35308306
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Since the initial breast transillumination almost a century ago, breast cancer imaging using light has been considered in different implementations aiming to improve diagnostics, minimize the number of available biopsies, or monitor treatment. However, due to strong photon scattering, conventional optical imaging yields low resolution images, challenging quantification and interpretation. Optoacoustic imaging addresses the scattering limitation and yields high-resolution visualization of optical contrast, offering great potential value for breast cancer imaging. Nevertheless, the image quality of experimental systems remains limited due to a number of factors, including signal attenuation with depth and partial view angle and motion effects, particularly in multi-wavelength measurements.

Methods: We developed data analytics methods to improve the accuracy of handheld optoacoustic breast cancer imaging, yielding second-generation optoacoustic imaging performance operating in tandem with ultrasonography.

Results: We produced the most advanced images yet with handheld optoacoustic examinations of the human breast and breast cancer, in terms of resolution and contrast. Using these advances, we examined optoacoustic markers of malignancy, including vasculature abnormalities, hypoxia, and inflammation, on images obtained from breast cancer patients.

Conclusions: We achieved a new level of quality for optoacoustic images from a handheld examination of the human breast, advancing the diagnostic and theranostic potential of the hybrid optoacoustic-ultrasound (OPUS) examination over routine ultrasonography.

Citing Articles

Mixture prior distributions and Bayesian models for robust radionuclide image processing.

Zhang M, Aykroyd R, Tsoumpas C Front Nucl Med. 2024; 4:1380518.

PMID: 39355208 PMC: 11440870. DOI: 10.3389/fnume.2024.1380518.


A novel maternal thyroid disease prediction using multi-scale vision transformer architecture with improved linguistic hedges neural-fuzzy classifier.

H S, S K, R S Technol Health Care. 2024; 32(6):4381-4402.

PMID: 39058467 PMC: 11613024. DOI: 10.3233/THC-240362.


Mini review of photoacoustic clinical imaging: a noninvasive tool for disease diagnosis and treatment evaluation.

Liu H, Wang M, Ji F, Jiang Y, Yang M J Biomed Opt. 2024; 29(Suppl 1):S11522.

PMID: 38230369 PMC: 10790789. DOI: 10.1117/1.JBO.29.S1.S11522.


Advances in photoacoustic imaging aided by nano contrast agents: special focus on role of lymphatic system imaging for cancer theranostics.

Sridharan B, Lim H J Nanobiotechnology. 2023; 21(1):437.

PMID: 37986071 PMC: 10662568. DOI: 10.1186/s12951-023-02192-8.


Optical Breast Imaging: A Review of Physical Principles, Technologies, and Clinical Applications.

Poplack S, Park E, Ferrara K J Breast Imaging. 2023; 5(5):520-537.

PMID: 37981994 PMC: 10655724. DOI: 10.1093/jbi/wbad057.


References
1.
Heijblom M, Piras D, Brinkhuis M, van Hespen J, van den Engh F, van der Schaaf M . Photoacoustic image patterns of breast carcinoma and comparisons with Magnetic Resonance Imaging and vascular stained histopathology. Sci Rep. 2015; 5:11778. PMC: 4498178. DOI: 10.1038/srep11778. View

2.
Toi M, Asao Y, Matsumoto Y, Sekiguchi H, Yoshikawa A, Takada M . Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array. Sci Rep. 2017; 7:41970. PMC: 5294462. DOI: 10.1038/srep41970. View

3.
Tromberg B, Zhang Z, Leproux A, OSullivan T, Cerussi A, Carpenter P . Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging. Cancer Res. 2016; 76(20):5933-5944. PMC: 5148152. DOI: 10.1158/0008-5472.CAN-16-0346. View

4.
Jiang S, Pogue B, Kaufman P, Gui J, Jermyn M, Frazee T . Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment. Clin Cancer Res. 2014; 20(23):6006-15. PMC: 4254218. DOI: 10.1158/1078-0432.CCR-14-1415. View

5.
Achilefu S . Lighting up tumors with receptor-specific optical molecular probes. Technol Cancer Res Treat. 2004; 3(4):393-409. DOI: 10.1177/153303460400300410. View